Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 1/20 | 0.38 |
| ▸ | HTR4 | Q13639 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | PTGES | O14684 | 1/20 | 0.34 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.33 |
| ▸ | SSTR4 | P31391 | 3/20 | 0.33 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.32 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.32 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5161244 | 0.91 | PARP1 (0.40) | PARP1HTR4MAPTNPSR1RXFP1 | |
| SCHEMBL4964558 | 0.83 | PARP1 (0.48) | PARP1MAPTNPSR1RXFP1PTGES | |
| SCHEMBL5156424 | 0.82 | MAPT (0.44) | PARP1MAPTNPSR1RXFP1PTGES | |
| SCHEMBL5161120 | 0.81 | PARP1 (0.43) | PARP1MAPTNPSR1RXFP1PTGES | |
| SCHEMBL5161027 | 0.79 | HPGD (0.41) | MAPTRXFP1KCNA3 | |
| SCHEMBL3639066 | 0.71 | PARP1 (0.57) | PARP1HTR4MAPTKCNA3MAPK14 | |
| SCHEMBL5160739 | 0.68 | HPGD (0.44) | MAPTNPSR1KCNA3HCRTR1 | |
| SCHEMBL3645399 | 0.66 | PARP1 (0.56) | PARP1PTGESKCNA3SSTR4HCRTR1 | |
| SCHEMBL7980334 | 0.65 | PARP1 (0.66) | PARP1KCNA3SSTR4HCRTR1HCRTR2 | |
| SCHEMBL3639059 | 0.65 | PARP1 (0.57) | PARP1MAPTNPSR1RXFP1PTGES |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1126836-B1 | BENZAMIDE POTASSIUM CHANNEL INHIBITORS | MERCK & CO INC (US) | 2007-02-14 | — | — | EP | disclosed |
| EP-1126836-A4 | BENZAMIDE POTASSIUM CHANNEL INHIBITORS | MERCK & CO INC (US) | 2002-09-04 | — | — | EP | disclosed |
| EP-1126836-A1 | BENZAMIDE POTASSIUM CHANNEL INHIBITORS | Merck & Co., Inc. (US) | 2001-08-29 | — | — | EP | disclosed |
| US-6194458-B1 | 1-(2-METHOXYPHENYL)-1-OXO-2-AZA-(S)-4-I-BUTYL-4-PHENYLBUTANE, FOR EXAMPLE; TREATING VARIOUS CONDITIONS INCLUDING TRANSPLANTATION REJECTION OF ORGANS OR TISSUES IN A PATIENT; IMMUNOSUPPRESSANT COMPOSITIONS | MERCK & CO., INC. | 2001-02-27 | — | — | US | disclosed |
| WO-2000025774-A1 | BENZAMIDE POTASSIUM CHANNEL INHIBITORS | MERCK & CO., INC. (US) | 2000-05-11 | — | — | WO | disclosed |